Wolverine Trading’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,200
Closed -$215K 5113
2023
Q3
$215K Buy
+5,200
New +$229K ﹤0.01% 3677
2020
Q3
Sell
-17,200
Closed -$483K 5059
2020
Q2
$483K Buy
+17,200
New +$485K ﹤0.01% 2769
2018
Q1
Sell
-9,600
Closed -$212K 5734
2017
Q4
$212K Sell
9,600
-3,200
-25% -$69.5K ﹤0.01% 4072
2017
Q3
$274K Buy
+12,800
New +$263K ﹤0.01% 3389
2016
Q3
Sell
-13,200
Closed -$207K 5041
2016
Q2
$207K Buy
+13,200
New +$204K ﹤0.01% 3246

Other funds holding RXL

Wolverine Trading's RXL Position: Q4 2020 in Review

Wolverine Trading sold out of ProShares Ultra Health Care (RXL) in Q4 2020, closing a stake of 13,884 shares — an estimated $438K sold.

Wolverine Trading first reported a position in RXL in Q3 2017 and held it in 6 quarters. The position peaked at $438K in Q3 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q4 2020.

  • Wolverine Trading reported no remaining ProShares Ultra Health Care position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 13,884 ProShares Ultra Health Care shares in Q4 2020, an estimated $438K.
  • Wolverine Trading first reported a position in ProShares Ultra Health Care in Q3 2017 and held it in 6 quarters.
  • Wolverine Trading's ProShares Ultra Health Care position peaked at $438K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.